Mark Milton-Edwards

Head of Product & Health Solutions - Digital Health at Teva Pharmaceuticals

Mark is responsible for the Product & Health Solutions within Digital Health at TEVA Pharmaceuticals. Over ten years with TEVA and prior to that sixteen with AstraZeneca. Mark has held various positions including R&D Project Leader, VP Sales & Marketing, Strategic Planning & Business Development, and Global Brand Lead.

Graduated in Aeronautical Sciences and completed his MBA at Durham University, UK. During his career he has led technology & especially inhaler development teams through engineering, CMC characterisation, clinical evidence generation, registration within US, EU and International Markets and ultimately to successful global launch. Total Brand Leadership value >$2.5bn. Mark has numerous patents granted and pending in electronic communications, sports technologies, inhaled pharmaceutical development, and respiratory physiological function & predictive AI.

Mark is the inventor of Digihaler®, the first FDA approved digital inhaler with built-in sensors.

Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Gallery

Development of an Integrated Digital Health Product (DigihalerTM)

 

 

 

 

 

Other Speakers from the IRDD Summit 2020

Justin Kalafat

Scientific Business Development Manager at ACG

Masahiro Sakagami

Professor of Pharmaceutics at Virginia Commonwealth University

Michael Castagna

Chief Executive Officer at MannKind Corporation